Internal Medicine, Geriatric Medicine · Rancho Mirage, CA
NPI
1982799813
Since 2006
Specialty
Internal Medicine, Geriatric Medicine
Code 207RG0300X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
72047 Dinah Shore Drive, Suite C4
Rancho Mirage, CA, 92270
Phone (760) 770-7600
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
30,130 services
Medicare patients, 2024
892
Average age 77
Drug cost, 2024
$1.6M
15,199 prescriptions
Company payments, 2025
$409
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rupinder Mann was code J3111 (injection, romosozumab-aqqg, 1 mg), 10,500 times for 11 patients. In total Rupinder Mann billed 30,130 services in 52 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 10,500 | 11 | $8.64 | $91K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 5,303 | 537 | $50.04 | $265K |
| J0897 Injection, denosumab, 1 mg | Office | 4,140 | 41 | $20.61 | $85K |
| 99214 Office E&M - Established | Office | 2,073 | 709 | $103.24 | $214K |
| 99457 E&M - Miscellaneous | Office | 1,889 | 217 | $40.19 | $76K |
| 99454 E&M - Miscellaneous | Office | 1,638 | 207 | $40.18 | $66K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 905 | 501 | $13.10 | $12K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 694 | 11 | $0.10 | $70.62 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 586 | 586 | $133.16 | $78K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 468 | 468 | $19.74 | $9,238 |
| 99350 Home E&M - New and Established | Office | 299 | 36 | $142.84 | $43K |
| 99213 Office E&M - Established | Office | 288 | 230 | $73.17 | $21K |
| 96372 Injection Administration | Office | 144 | 61 | $11.83 | $1,703 |
| 99497 Care Management/Coordination | Office | 129 | 125 | $70.89 | $9,145 |
| 99483 Office/Outpatient Services | Office | 102 | 101 | $223.97 | $23K |
By year: 2022 $1.0M for 20,782 services; 2023 $1.1M for 25,309 services; 2024 $1.1M for 30,130 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82043 Clinical Chemistry | 70 | 69 | $5.66 | $396 |
| 80048 Clinical Chemistry | 68 | 67 | $8.29 | $564 |
Medicare prescription drug claims, 2024
In 2024, the drug Rupinder Mann prescribed most often to Medicare patients was Atorvastatin Calcium, with 927 prescriptions and refills. In total Rupinder Mann wrote 15,199 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 927 | 2,327 | 246 | $9,606 |
| Levothyroxine Sodium Generic | 807 | 2,059 | 213 | $8,436 |
| Losartan Potassium Generic | 700 | 1,773 | 193 | $7,339 |
| Amlodipine Besylate Generic | 460 | 1,104 | 125 | $4,150 |
| Rosuvastatin Calcium Generic | 424 | 1,126 | 141 | $7,138 |
| Pantoprazole Sodium Generic | 366 | 843 | 122 | $4,900 |
| Metoprolol Succinate Generic | 299 | 769 | 87 | $4,718 |
| Lisinopril Generic | 286 | 706 | 82 | $2,256 |
| Duloxetine Hcl Generic | 267 | 495 | 55 | $5,801 |
| Metformin Hcl Generic | 249 | 610 | 68 | $1,871 |
| Gabapentin Generic | 246 | 561 | 85 | $6,367 |
| Alprazolam Generic | 242 | 319 | 77 | $2,100 |
| Jardiance Empagliflozin | 231 | 512 | 62 | $290K |
| Furosemide Generic | 227 | 556 | 70 | $1,412 |
| Montelukast Sodium Generic | 225 | 585 | 74 | $3,154 |
Brand drugs: 1,890 claims; generic drugs: 13,234 claims; opioid claims: 217.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rupinder Mann $409 ($409 in general payments such as food, travel and fees) from 10 companies. The largest payer was Amgen Inc. with $109.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 5 | $109 |
| Lilly USA, LLC LLY | 3 | $58.93 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $48.55 |
| Novo Nordisk Inc NVO | 2 | $45.11 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $43.82 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $33.43 |
| Pfizer Inc. PFE | 1 | $25.74 |
| Acella Pharmaceuticals, LLC | 1 | $15.19 |
| Philips North America LLC PHG | 1 | $14.78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.